Announcements Trials
Browse Landscape

Status

Completed 12Unknown 6Active not recruiting 4Recruiting 3Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Head & Neck 1

Conditions

Recurrence 1Neoplasms 1Mouth Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × High-Throughput Nucleotide Sequencing × Clear all
NCT05605379 2024-08-14

CML Piramid

University Hospital, Bordeaux

Recruiting
88 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05382585 2024-08-13

Newer Therapeutic Targets in Head and Neck Cancers

Banaras Hindu University

Recruiting
200 enrolled
Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Recruiting
3,500 enrolled

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡